Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 387

1.

Ranolazine triggers pharmacological preconditioning and postconditioning in anesthetized rabbits through activation of RISK pathway.

Efentakis P, Andreadou I, Bibli SI, Vasileiou S, Dagres N, Zoga A, Lougiakis N, Kremastinos DT, Iliodromitis EK.

Eur J Pharmacol. 2016 Oct 15;789:431-438. doi: 10.1016/j.ejphar.2016.08.001. Epub 2016 Aug 2.

PMID:
27492365
2.

Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.

Bibli SI, Andreadou I, Chatzianastasiou A, Tzimas C, Sanoudou D, Kranias E, Brouckaert P, Coletta C, Szabo C, Kremastinos DT, Iliodromitis EK, Papapetropoulos A.

Cardiovasc Res. 2015 Jun 1;106(3):432-42. doi: 10.1093/cvr/cvv129. Epub 2015 Apr 13.

3.

Transient carotid ischemia as a remote conditioning stimulus for myocardial protection in anesthetized rabbits: Insights into intracellular signaling.

Andreadou I, Bibli SI, Mastromanolis E, Zoga A, Efentakis P, Papaioannou N, Farmakis D, Kremastinos DT, Iliodromitis EK.

Int J Cardiol. 2015 Apr 1;184:140-51. doi: 10.1016/j.ijcard.2015.01.079. Epub 2015 Feb 7.

PMID:
25703422
4.

What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.

Iliodromitis EK, Cohen MV, Dagres N, Andreadou I, Kremastinos DT, Downey JM.

J Cardiovasc Pharmacol Ther. 2015 Jul;20(4):357-69. doi: 10.1177/1074248414566459. Epub 2015 Jan 26. Review.

PMID:
25627214
5.

Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events.

Eapen DJ, Manocha P, Ghasemzadeh N, Patel RS, Al Kassem H, Hammadah M, Veledar E, Le NA, Pielak T, Thorball CW, Velegraki A, Kremastinos DT, Lerakis S, Sperling L, Quyyumi AA.

J Am Heart Assoc. 2014 Oct 23;3(5):e001118. doi: 10.1161/JAHA.114.001118. Erratum in: J Am Heart Assoc. 2015 Jan;4(1):e000563. Ghasemzedah, Nima [Corrected to Ghasemzadeh, Nima]. Erratum in: J Am Heart Assoc. 2015 Jan 5;4(1):e000563.

6.

Exhaled breath condensate in acute and chronic heart failure: new insights into the role of lung injury and barrier dysfunction.

Pappas LK, Giannopoulos G, Loukides S, Gavrielatos G, Athanasopoulou E, Alexanian IP, Farmakis D, Korovesi I, Letsas KP, Parissis JT, Deftereos S, Pyrgakis VN, Kotanidou A, Kremastinos DT, Filippatos GS.

Am J Respir Crit Care Med. 2014 Aug 1;190(3):342-5. doi: 10.1164/rccm.201402-0272LE. No abstract available.

PMID:
25084262
7.

Pharmacological postconditioning of the rabbit heart with non-selective, A1 , A2A and A3 adenosine receptor agonists.

Bibli SI, Iliodromitis EK, Lambertucci C, Zoga A, Lougiakis N, Dagres N, Volpini R, Dal Ben D, Kremastinos DT, Tsantili Kakoulidou A, Cristalli G, Andreadou I.

J Pharm Pharmacol. 2014 Aug;66(8):1140-9. doi: 10.1111/jphp.12238. Epub 2014 Apr 27.

PMID:
24766266
8.

Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism.

Andreadou I, Mikros E, Ioannidis K, Sigala F, Naka K, Kostidis S, Farmakis D, Tenta R, Kavantzas N, Bibli SI, Gikas E, Skaltsounis L, Kremastinos DT, Iliodromitis EK.

J Mol Cell Cardiol. 2014 Apr;69:4-16. doi: 10.1016/j.yjmcc.2014.01.007. Epub 2014 Jan 28.

PMID:
24486195
9.

A case-control validation of Type D personality in Greek patients with stable coronary heart disease.

Christodoulou C, Douzenis A, Mommersteeg PM, Rallidis L, Poulios A, Efstathiou V, Bouras G, Varounis C, Korkoliakou P, Palios J, Kremastinos DT, Lykouras L.

Ann Gen Psychiatry. 2013 Nov 27;12(1):38. doi: 10.1186/1744-859X-12-38.

10.

Assessment of left ventricular and atrial diastolic function using two-dimensional (2D) strain imaging in patients with β-thalassemia major.

Karamanou AG, Hamodraka ES, Vrakas SC, Paraskevaidis I, Lekakis I, Kremastinos DT.

Eur J Haematol. 2014 Jan;92(1):59-65. doi: 10.1111/ejh.12209. Epub 2013 Nov 11.

PMID:
24118422
11.

The pathophysiological relationship and clinical significance of left atrial function and left ventricular diastolic dysfunction in β-thalassemia major.

Kostopoulou AG, Tsiapras DP, Chaidaroglou AS, De Giannis DE, Farmakis D, Kremastinos DT.

Am J Hematol. 2014 Jan;89(1):13-8. doi: 10.1002/ajh.23581. Epub 2013 Sep 19.

12.

Coronary artery ectasia and inflammatory cytokines: link with a predominant Th-2 immune response?

Triantafyllis AS, Kalogeropoulos AS, Rigopoulos AG, Sakadakis EA, Toumpoulis IK, Tsikrikas S, Kremastinos DT, Rizos I.

Cytokine. 2013 Oct;64(1):427-32. doi: 10.1016/j.cyto.2013.05.003. Epub 2013 Jun 4.

PMID:
23742784
13.

Clinical and neurohormonal correlates and prognostic value of serum prolactin levels in patients with chronic heart failure.

Parissis JT, Farmakis D, Fountoulaki K, Rigas A, Nikolaou M, Paraskevaidis IA, Bistola V, Venetsanou K, Ikonomidis I, Anastasiou-Nana M, Kremastinos DT, Filippatos G.

Eur J Heart Fail. 2013 Oct;15(10):1122-30. doi: 10.1093/eurjhf/hft070. Epub 2013 May 2.

14.

Revealing infective endocarditis complications by echocardiography: the value of real-time 3D transesophageal echocardiography.

Vrettou AR, Zacharoulis A, Lerakis S, Kremastinos DT.

Hellenic J Cardiol. 2013 Mar-Apr;54(2):147-9.

15.

Various models of cardiac conditioning in single or sequential periods of ischemia: comparative effects on infarct size and intracellular signaling.

Iliodromitis K, Farmakis D, Andreadou I, Zoga A, Bibli SI, Manolaki T, Dagres N, Iliodromitis EK, Anastasiou-Nana M, Kremastinos DT.

Int J Cardiol. 2013 Sep 30;168(2):1336-41. doi: 10.1016/j.ijcard.2012.12.014. Epub 2012 Dec 25.

PMID:
23270747
16.

Ovariectomy reinstates the infarct size-limiting effect of postconditioning in female rabbits.

Demerouti E, Andreadou I, Aggeli IK, Farmakis D, Zoga A, Gaitanaki C, Beis I, Anastasiou-Nana M, Kremastinos DT, Iliodromitis EK.

Cell Biochem Biophys. 2013 Apr;65(3):373-80. doi: 10.1007/s12013-012-9441-3.

PMID:
23070726
17.

Effective sleep apnoea treatment improves cardiac function in patients with chronic heart failure.

Kourouklis SP, Vagiakis E, Paraskevaidis IA, Farmakis D, Kostikas K, Parissis JT, Katsivas A, Kremastinos DT, Anastasiou-Nana M, Filippatos G.

Int J Cardiol. 2013 Sep 20;168(1):157-62. doi: 10.1016/j.ijcard.2012.09.101. Epub 2012 Oct 2.

PMID:
23041002
18.

Discovery of 6-[4-(6-nitroxyhexanoyl)piperazin-1-yl)]-9H-purine, as pharmacological post-conditioning agent.

Koufaki M, Fotopoulou T, Iliodromitis EK, Bibli SI, Zoga A, Kremastinos DT, Andreadou I.

Bioorg Med Chem. 2012 Oct 1;20(19):5948-56. doi: 10.1016/j.bmc.2012.07.037. Epub 2012 Jul 31.

PMID:
22925446
19.

Understanding mitral valve pathology: three-dimensional transesophageal echocardiography parametric maps.

Vrettou AR, Zacharoulis A, Kremastinos DT, Lerakis S.

Hellenic J Cardiol. 2012 May-Jun;53(3):234-6. No abstract available.

20.

Epicardial and pericardial adipose tissue: physiological importance and role of imaging techniques.

Arepalli CD, Vrettoy RA, Lamanna JJ, Ebert EL, Kremastinos DT, Lerakis S.

Minerva Cardioangiol. 2012 Jun;60(3):299-304. Review.

PMID:
22653044
21.

Arterial stiffness is associated with increased monocyte expression of adiponectin receptor mRNA and protein in patients with coronary artery disease.

Ikonomidis I, Kadoglou N, Tsiotra PC, Kollias A, Palios I, Fountoulaki K, Halvatsiotis I, Maratou E, Dimitriadis G, Kremastinos DT, Lekakis J, Raptis SA.

Am J Hypertens. 2012 Jul;25(7):746-55. doi: 10.1038/ajh.2012.42. Epub 2012 Apr 26.

PMID:
22534793
22.

Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress.

Andreadou I, Farmakis D, Prokovas E, Sigala F, Zoga A, Spyridaki K, Papalois A, Papapetropoulos A, Anastasiou-Nana M, Kremastinos DT, Iliodromitis EK.

Cardiovasc Res. 2012 Jun 1;94(3):501-9. doi: 10.1093/cvr/cvs121. Epub 2012 Mar 12.

PMID:
22411971
23.

Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heart.

Hausenloy DJ, Iliodromitis EK, Andreadou I, Papalois A, Gritsopoulos G, Anastasiou-Nana M, Kremastinos DT, Yellon DM.

Cardiovasc Drugs Ther. 2012 Apr;26(2):87-93. doi: 10.1007/s10557-011-6364-y.

PMID:
22207395
24.

Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation.

Kalogeropoulos AS, Tsiodras S, Rigopoulos AG, Sakadakis EA, Triantafyllis A, Kremastinos DT, Rizos I.

BMC Cardiovasc Disord. 2011 Dec 28;11:77. doi: 10.1186/1471-2261-11-77.

25.

Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype.

Seegers J, Vos MA, Flevari P, Willems R, Sohns C, Vollmann D, Lüthje L, Kremastinos DT, Floré V, Meine M, Tuinenburg A, Myles RC, Simon D, Brockmöller J, Friede T, Hasenfuß G, Lehnart SE, Zabel M; EUTrigTreat Clinical Study Investigators.

Europace. 2012 Mar;14(3):416-22. doi: 10.1093/europace/eur352. Epub 2011 Nov 23.

26.

Iron overload cardiomyopathy in clinical practice.

Kremastinos DT, Farmakis D.

Circulation. 2011 Nov 15;124(20):2253-63. doi: 10.1161/CIRCULATIONAHA.111.050773. Review. No abstract available.

PMID:
22083147
27.

Three dimensional trans-esophageal echocardiography for the evaluation of flail mitral valve.

Kobylivker A, Vrettou AR, Lerakis S, Kremastinos DT.

Hellenic J Cardiol. 2011 Sep-Oct;52(5):442-3. No abstract available.

28.

Investigating the effect of antioxidant treatment on the protective effect of preconditioning in anesthetized rabbits.

Andreadou I, Iliodromitis EK, Souridis V, Prokovas E, Kostidis S, Zoga A, Dagres N, Tsantili-Kakoulidou A, Kremastinos DT, Mikros E, Anastasiou-Nana M.

J Cardiovasc Pharmacol. 2011 Dec;58(6):609-16. doi: 10.1097/FJC.0b013e31822fc783.

PMID:
21822143
29.

Effects of adiponectin in TNF-α, IL-6, and IL-10 cytokine production from coronary artery disease macrophages.

Kyriazi E, Tsiotra PC, Boutati E, Ikonomidis I, Fountoulaki K, Maratou E, Lekakis J, Dimitriadis G, Kremastinos DT, Raptis SA.

Horm Metab Res. 2011 Jul;43(8):537-44. doi: 10.1055/s-0031-1277227. Epub 2011 May 30.

PMID:
21626471
30.

Biomarkers of myocardial injury as surrogate end-points for remote ischemic conditioning trials.

Iliodromitis EK, Farmakis D, Kremastinos DT.

Int J Cardiol. 2011 Jun 16;149(3):379. doi: 10.1016/j.ijcard.2011.02.067. Epub 2011 Mar 17. No abstract available.

PMID:
21419504
31.

Detection of high-burden coronary artery disease by exercise-induced changes of the E/E' ratio.

Tsougos E, Paraskevaidis I, Dagres N, Varounis C, Panou F, Karatzas D, Trapali X, Iliodromitis E, Kremastinos DT.

Int J Cardiovasc Imaging. 2012 Mar;28(3):521-30. doi: 10.1007/s10554-011-9840-3. Epub 2011 Mar 11.

PMID:
21394613
32.

Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease.

Kollias A, Tsiotra PC, Ikonomidis I, Maratou E, Mitrou P, Kyriazi E, Boutati E, Lekakis J, Economopoulos T, Kremastinos DT, Dimitriadis G, Raptis SA.

Cardiovasc Diabetol. 2011 Feb 1;10:14. doi: 10.1186/1475-2840-10-14.

33.

Cytokine gene polymorphisms are associated with markers of disease severity and prognosis in patients with idiopathic dilated cardiomyopathy.

Adamopoulos S, Kolokathis F, Gkouziouta A, Georgiadou P, Chaidaroglou A, Karavolias GK, Degiannis D, Voudris V, Kremastinos DT.

Cytokine. 2011 Apr;54(1):68-73. doi: 10.1016/j.cyto.2011.01.004. Epub 2011 Feb 1.

PMID:
21282066
34.

Total ventricular assist for long-term treatment of heart failure.

Pitsis AA, Visouli AN, Ninios V, Kremastinos DT.

J Thorac Cardiovasc Surg. 2011 Aug;142(2):464-7. doi: 10.1016/j.jtcvs.2010.11.014. Epub 2011 Feb 1. No abstract available.

35.

Left ventricular assist device vegetation: "cure" without device explantation.

Gogas BD, Parissis JT, Iliodromitis EK, Tsiodras S, Radu M, Paraskevaidis IA, Theodoropoulos SP, Kremastinos DT, Yacoub MH.

Hellenic J Cardiol. 2010 Nov-Dec;51(6):549-51.

36.

Staccato reperfusion improves myocardial microcirculatory function and long-term left ventricular remodelling: a randomised contrast echocardiography study.

Ikonomidis I, Iliodromitis EK, Tzortzis S, Antoniadis A, Paraskevaidis I, Andreadou I, Fountoulaki K, Farmakis D, Kremastinos DT, Anastasiou-Nana M.

Heart. 2010 Dec;96(23):1898-903. doi: 10.1136/hrt.2010.201681.

PMID:
21062779
37.

Rapid ventricular pacing: a fast, reliable, and safe technique for optimization of image acquisition during rotational angiography for catheter ablation of atrial fibrillation.

Hilbert S, Dagres N, Hindricks G, Sommer P, Gaspar T, Rallidis LS, Kremastinos DT, Piorkowski C.

Heart Vessels. 2011 May;26(3):349-52. doi: 10.1007/s00380-010-0023-2. Epub 2010 Oct 21.

PMID:
20963596
38.

C-reactive protein, interleukin 6, and N-terminal pro-brain natriuretic peptide following cardioversion of atrial fibrillation: is there a role of biomarkers in arrhythmia recurrence?

Psychari SN, Chatzopoulos D, Iliodromitis EK, Apostolou TS, Kremastinos DT.

Angiology. 2011 May;62(4):310-6. doi: 10.1177/0003319710382418. Epub 2010 Sep 11.

PMID:
20834028
39.

Relationship between individual cardiovascular risk factors and localization of coronary atherosclerotic lesions.

Trianti M, Xanthos T, Iacovidou N, Dagres N, Lekakis JP, Kyriakou F, Kremastinos DT.

Heart Lung. 2011 May-Jun;40(3):201-7. doi: 10.1016/j.hrtlng.2010.06.007. Epub 2010 Aug 23.

PMID:
20739064
40.

Drug-eluting stents: where are we today?

Kremastinos DT, Farmakis DT, Anastasiou-Nana M.

Hellenic J Cardiol. 2010 Jul-Aug;51(4):287-9. No abstract available.

41.

Contemporary practices in postcardiac arrest syndrome: the role of mild therapeutic hypothermia.

Gavrielatos G, Werner KD, Voridis E, Kremastinos DT.

Ther Adv Cardiovasc Dis. 2010 Oct;4(5):325-33. doi: 10.1177/1753944710373786. Epub 2010 Jun 23. Review.

PMID:
20573637
42.

Aortic distensibility associates with increased ascending thoracic aorta diameter and left ventricular diastolic dysfunction in patients with coronary artery ectasia.

Triantafyllidi H, Rizos I, Rallidis L, Tsikrikas S, Triantafyllis A, Ikonomidis I, Panou F, Rigopoulos A, Kremastinos DT.

Heart Vessels. 2010 May;25(3):187-94. doi: 10.1007/s00380-009-1196-4. Epub 2010 May 29.

PMID:
20512445
43.

The role of the selective serotonin re-uptake inhibitor sertraline in nondepressive patients with chronic ischemic heart failure: a preliminary study.

Leftheriotis D, Flevari P, Ikonomidis I, Douzenis A, Liapis C, Paraskevaidis I, Iliodromitis E, Lykouras L, Kremastinos DT.

Pacing Clin Electrophysiol. 2010 Oct;33(10):1217-23. doi: 10.1111/j.1540-8159.2010.02792.x.

PMID:
20487349
44.

Exercise-induced changes of B-type natriuretic peptide uncover the unknown coronary artery disease in patients with chest pain and normal left ventricular systolic function.

Paraskevaidis IA, Tsougos E, Varounis C, Dagres N, Karatzas D, Parissis J, Kremastinos DT.

Eur J Cardiovasc Prev Rehabil. 2011 Feb;18(1):72-8. doi: 10.1097/HJR.0b013e32833a4529.

PMID:
20485180
45.

Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives.

Kremastinos DT, Farmakis D, Aessopos A, Hahalis G, Hamodraka E, Tsiapras D, Keren A.

Circ Heart Fail. 2010 May;3(3):451-8. doi: 10.1161/CIRCHEARTFAILURE.109.913863. Review.

PMID:
20484195
46.

Chronic hind limb ischemia reduces myocardial ischemia-reperfusion injury in the rabbit heart by promoting coronary angiogenesis/arteriogenesis.

Varnavas VC, Paraskevas KI, Iliodromitis EK, Zoga A, Glava I, Kaklamanis L, Spartinos J, Lyras T, Kremastinos DT, Mikhailidis DP, Kyriakides ZS.

In Vivo. 2010 Mar-Apr;24(2):147-52.

PMID:
20363986
47.

Hypertension study in anaesthetized rabbits: protocol proposal for AT1 antagonists screening.

Politi AP, Zervou MV, Triantafyllidi H, Zoumpoulakis PG, Mavromoustakos TM, Zoga AA, Moutevelis-Minakakis P, Kokotos G, Iliodromitis EK, Kremastinos DT.

J Renin Angiotensin Aldosterone Syst. 2010 Jun;11(2):103-10. doi: 10.1177/1470320310365016. Epub 2010 Mar 31.

PMID:
20357048
48.

Functional electrical stimulation is more effective in severe symptomatic heart failure patients and improves their adherence to rehabilitation programs.

Karavidas A, Parissis JT, Matzaraki V, Arapi S, Varounis C, Ikonomidis I, Grillias P, Paraskevaidis I, Pirgakis V, Filippatos G, Kremastinos DT.

J Card Fail. 2010 Mar;16(3):244-9. doi: 10.1016/j.cardfail.2009.10.023. Epub 2009 Dec 11.

PMID:
20206900
49.

Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study.

Georgiadou P, Iliodromitis EK, Kolokathis F, Varounis C, Gizas V, Mavroidis M, Capetanaki Y, Boudoulas H, Kremastinos DT.

Eur J Clin Invest. 2010 Apr;40(4):288-93. doi: 10.1111/j.1365-2362.2010.02257.x.

PMID:
20192976
50.

Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes.

Halvatsiotis I, Tsiotra PC, Ikonomidis I, Kollias A, Mitrou P, Maratou E, Boutati E, Lekakis J, Dimitriadis G, Economopoulos T, Kremastinos DT, Raptis SA.

Cardiovasc Diabetol. 2010 Feb 23;9:10. doi: 10.1186/1475-2840-9-10.

Supplemental Content

Loading ...
Support Center